Cell Line Development Market Size, Share & Trends Analysis Report
商品番号 : SMB-88138
| 出版社 | Grand View Research |
| 出版年月 | 2025年8月 |
| ページ数 | 130 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 5,950 |
| 種別 | 英文調査報告書 |
細胞株開発市場 – 製品とサービス(試薬と培地、機器、付属品と消耗品)、ソース別、細胞株の種類別、用途別、地域、セグメント別予測による市場規模、成長と動向分析レポート 2025-2033年
世界の細胞株開発市場規模は、2024年には57億米ドルと推定され、2033年には134億6000万米ドルに達すると予測されています。2025年から2033年にかけて年平均成長率(CAGR)10.10%で成長が見込まれます。この成長は、バイオ医薬品の需要増加、研究開発投資の増加、そして細胞培養技術の進歩によって牽引されています。自動化、シングルユースシステム、CRISPRベースの編集といったイノベーションは効率性を高め、予測期間を通じて普及を促進します。
バイオテクノロジーの急速な進歩は、細胞株開発市場の発展を牽引する上で極めて重要です。自動化、ハイスループットスクリーニング、シングルユースバイオプロセス技術といった革新的なツールは、細胞株作製のスピード、効率、そして費用対効果を大幅に向上させました。自動化とデジタル化は、手作業によるミスを減らし、開発期間を短縮し、大規模な並行実験を可能にすることで、企業の製品パイプラインの加速を可能にします。
Cell Line Development Market Summary
The global cell line development market size was estimated at USD 5.70 billion in 2024 and is projected to reach USD 13.46 billion by 2033, growing at a CAGR of 10.10% from 2025 to 2033. The growth is fueled by rising demand for biopharmaceuticals, increasing R&D investments, and advancements in cell culture technologies. Innovations such as automation, single-use systems, and CRISPR-based editing enhance efficiency, driving adoption through the forecast period.

Technological Advancements in Cell Line Development
Rapid advancements in biotechnology are pivotal in driving the cell line development market forward. Innovative tools such as automation, high-throughput screening, and single-use bioprocessing technologies have significantly enhanced cell line generation’s speed, efficiency, and cost-effectiveness. Automation and digitalization reduce manual errors, shorten development timelines, and enable large-scale parallel experiments, allowing companies to accelerate product pipelines.
Moreover, cutting-edge genome editing tools like CRISPR/Cas9 are revolutionizing the precision and reliability of cell line engineering. These technologies allow targeted modifications, improved gene expression, and the development of high-yield cell lines with enhanced stability and productivity. Such innovations support the manufacturing of complex biologics and address the growing need for personalized and next-generation therapies. Technological advancements are establishing themselves as a core growth driver by enabling faster turnaround, reduced costs, and greater consistency, ensuring that cell line development remains a critical enabler of progress in the biopharmaceutical industry.
Cell Line Development Market Report Scope
| Report Attribute | Details |
| Market size value in 2025 | USD 6.23 billion |
| Revenue forecast in 2033 | USD 13.46 billion |
| Growth rate | CAGR of 10.10% from 2025 to 2033 |
| Base year for estimation | 2024 |
| Historical data | 2021 – 2023 |
| Forecast period | 2025 – 2033 |
| Quantitative units | Revenue in USD million/billion and CAGR from 2025 to 2033 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Product & services, source, type of cell lines, application, region |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Country scope | U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; India; China; Japan; Australia; South Korea; Thailand; Brazil; Argentina; Saudi Arabia; UAE; South Africa; Kuwait |
| Key companies profiled | Thermo Fisher Scientific Inc.; Corning Inc.; Lonza; Creative BioLabs.; WuXi PharmaTech; Sartorius AG; Merck KGaA; Advanced Instruments; Berkeley Lights; Danaher |
| Customization scope | Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Cell Line Development Market Report Segmentation
This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global cell line development market report on the basis of product & services, source, type of cell lines, application, and region:
- Product & Service Outlook (Revenue, USD Million, 2021 – 2033)
- Reagents and media
- Equipment
o Automated Systems
o Centrifuges
o Bioreactors
o Storage equipment
o Others
- Accessories & consumables
- Services
- Source Outlook (Revenue, USD Million, 2021 – 2033)
- Mammalian cell line
- Non-mammalian cell line
o Insects
o Amphibians
- Type of Cell Lines Outlook (Revenue, USD Million, 2021 – 2033)
- Recombinant cell lines
- Hybridomas
- Continuous cell lines
- Primary cell lines
- Application Outlook (Revenue, USD Million, 2021 – 2033)
- Bioproduction
- Drug discovery
- Toxicity testing
- Tissue engineering & Regenerative Medicine
- Others
- Regional Outlook (Revenue, USD Million, 2021 – 2033)
- North America
o U.S.
o Canada
o Mexico
- Europe
o Germany
o UK
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
- Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Thailand
- Latin America
o Brazil
o Argentina
- Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Product & Services
1.1.2. Source
1.1.3. Type of Cell Lines
1.1.4. Application
1.2. Market Definitions
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Others
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Growing biopharmaceutical production
3.3.1.2. Technological advancements
3.4. Market Restraint Analysis
3.4.1.1. Presence of complicated regulatory framework
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
Chapter 4. Product & Services Business Analysis
4.1. Product & Services Segment Dashboard
4.2. Global Cell Line Development Market: Product & Services Movement Analysis
4.3. Global Cell Line Development Market Size & Trend Analysis, by Product & Services, 2021 to 2033 (USD Million)
4.4. Reagents and Media
4.4.1. Reagents and Media Market, 2021 – 2033 (USD Million)
4.5. Equipment
4.5.1. Equipment Market, 2021 – 2033 (USD Million)
4.5.2. Automated Systems
4.5.2.1. Automated Systems Market, 2021 – 2033 (USD Million)
4.5.3. Centrifuges
4.5.3.1. Centrifuges Market, 2021 – 2033 (USD Million)
4.5.4. Bioreactors
4.5.4.1. Bioreactors Market, 2021 – 2033 (USD Million)
4.5.5. Storage Equipment
4.5.5.1. Storage Equipment Market, 2021 – 2033 (USD Million)
4.5.6. Others
4.5.6.1. Others Market, 2021 – 2033 (USD Million)
4.6. Accessories and Consumables
4.6.1. Accessories and Consumables Market, 2021 – 2033 (USD Million)
4.7. Services
4.7.1. Services Market, 2021 – 2033 (USD Million)
Chapter 5. Source Business Analysis
5.1. Source Segment Dashboard
5.2. Global Cell Line Development Market: Source Movement Analysis
5.3. Global Cell Line Development Market Size & Trend Analysis, by Source, 2021 to 2033 (USD Million)
5.4. Mammalian Cell Line
5.4.1. Mammalian Cell Line Market, 2021 – 2033 (USD Million)
5.5. Non-Mammalian Cell Line
5.5.1. Non-Mammalian Cell Line Market, 2021 – 2033 (USD Million)
5.5.2. Insects
5.5.2.1. Insects Market, 2021 – 2033 (USD Million)
5.5.3. Amphibians
5.5.3.1. Amphibians Market, 2021 – 2033 (USD Million)
Chapter 6. Type of Cell Lines Business Analysis
6.1. Type of Cell Lines Segment Dashboard
6.2. Global Cell Line Development Market: Type of Cell Lines Movement Analysis
6.3. Global Cell Line Development Market Size & Trend Analysis, by Type of Cell Lines, 2021 to 2033 (USD Million)
6.4. Recombinant Cell Lines
6.4.1. Recombinant Cell Lines Market, 2021 – 2033 (USD Million)
6.5. Hybridomas
6.5.1. Hybridomas Market, 2021 – 2033 (USD Million)
6.6. Continuous Cell Lines
6.6.1. Continuous Cell Lines Market, 2021 – 2033 (USD Million)
6.7. Primary Cell Lines
6.7.1. Primary Cell Lines Market, 2021 – 2033 (USD Million)
Chapter 7. Application Business Analysis
7.1. Application Segment Dashboard
7.2. Global Cell Line Development market: Application Movement Analysis
7.3. Global Cell Line Development Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
7.4. Bioproduction
7.4.1. Bioproduction Market, 2021 – 2033 (USD Million)
7.5. Drug Discovery
7.5.1. Drug Discovery Market, 2021 – 2033 (USD Million)
7.6. Toxicity Testing
7.6.1. Toxicity Testing Market, 2021 – 2033 (USD Million)
7.7. Tissue Engineering & Regenerative Medicine
7.7.1. Tissue Engineering & Regenerative Medicine Market, 2021 – 2033 (USD Million)
7.8. Others
7.8.1. Others Market, 2021 – 2033 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Global Cell Line Development Market Share By Region, 2024 & 2033
8.2. North America
8.2.1. North America Cell Line Development Market, 2021 – 2033 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. U.S. Cell Line Development Market, 2021 – 2033 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Canada Cell Line Development Market, 2021 – 2033 (USD Million)
8.2.4. Mexico
8.2.4.1. Key Country Dynamics
8.2.4.2. Competitive Scenario
8.2.4.3. Regulatory Framework
8.2.4.4. Mexico Cell Line Development Market, 2021 – 2033 (USD Million)
8.3. Europe
8.3.1. Europe Cell Line Development Market, 2021 – 2033 (USD Million)
8.3.2. Germany
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. Germany Cell Line Development Market, 2021 – 2033 (USD Million)
8.3.3. UK
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. UK Cell Line Development Market, 2021 – 2033 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. France Cell Line Development Market, 2021 – 2033 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Italy Cell Line Development Market, 2021 – 2033 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Spain Cell Line Development Market, 2021 – 2033 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Denmark Cell Line Development Market, 2021 – 2033 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Sweden Cell Line Development Market, 2021 – 2033 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Norway Cell Line Development Market, 2021 – 2033 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Cell Line Development Market, 2021 – 2033 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Japan Cell Line Development Market, 2021 – 2033 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. China Cell Line Development Market, 2021 – 2033 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. India Cell Line Development Market, 2021 – 2033 (USD Million)
8.4.5. South Korea
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. South Korea Cell Line Development Market, 2021 – 2033 (USD Million)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Australia Cell Line Development Market, 2021 – 2033 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Thailand Cell Line Development Market, 2021 – 2033 (USD Million)
8.5. Latin America
8.5.1. Latin America Cell Line Development Market, 2021 – 2033 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Brazil Cell Line Development Market, 2021 – 2033 (USD Million)
8.5.3. Argentina
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Argentina Cell Line Development Market, 2021 – 2033 (USD Million)
8.6. MEA
8.6.1. MEA Cell Line Development Market, 2021 – 2033 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. South Africa Cell Line Development Market, 2021 – 2033 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Saudi Arabia Cell Line Development Market, 2021 – 2033 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. UAE Cell Line Development Market, 2021 – 2033 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Kuwait Cell Line Development Market, 2021 – 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market/Position Share Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Danaher
9.4.2.1. Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Merck KGaA
9.4.3.1. Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Sartorius AG
9.4.4.1. Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Lonza
9.4.5.1. Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. WuXi PharmaTech
9.4.6.1. Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Advanced Instruments
9.4.7.1. Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Berkeley Lights
9.4.8.1. Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Creative BioLabs
9.4.9.1. Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Corning Inc.
9.4.10.1. Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
List of Tables
Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global cell line development market by product & services, 2021 – 2033 (USD Million)
Table 4 Global cell line development market by source, 2021 – 2033 (USD Million)
Table 5 Global cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 6 Global cell line development market by application, 2021 – 2033 (USD Million)
Table 7 Global cell line development market by region, 2021 – 2033 (USD Million)
Table 8 North America cell line development market by product & services, 2021 – 2033 (USD Million)
Table 9 North America cell line development market by source, 2021 – 2033 (USD Million)
Table 10 North America cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 11 North America cell line development market by application, 2021 – 2033 (USD Million)
Table 12 North America cell line development market by country, 2021 – 2033 (USD Million)
Table 13 U.S. cell line development market by product & services, 2021 – 2033 (USD Million)
Table 14 U.S. cell line development market by source, 2021 – 2033 (USD Million)
Table 15 U.S. cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 16 U.S. cell line development market by application, 2021 – 2033 (USD Million)
Table 17 Canada cell line development market by product & services, 2021 – 2033 (USD Million)
Table 18 Canada cell line development market by source, 2021 – 2033 (USD Million)
Table 19 Canada cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 20 Canada cell line development market by application, 2021 – 2033 (USD Million)
Table 21 Mexico cell line development market by product & services, 2021 – 2033 (USD Million)
Table 22 Mexico cell line development market by source, 2021 – 2033 (USD Million)
Table 23 Mexico cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 24 Mexico cell line development market by application, 2021 – 2033 (USD Million)
Table 25 Europe cell line development market by product & services, 2021 – 2033 (USD Million)
Table 26 Europe cell line development market by source, 2021 – 2033 (USD Million)
Table 27 Europe cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 28 Europe cell line development market by application, 2021 – 2033 (USD Million)
Table 29 Europe cell line development market by country, 2021 – 2033 (USD Million)
Table 30 UK cell line development market by product & services, 2021 – 2033 (USD Million)
Table 31 UK cell line development market by source, 2021 – 2033 (USD Million)
Table 32 UK cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 33 UK cell line development market by application, 2021 – 2033 (USD Million)
Table 34 Germany cell line development market by product & services, 2021 – 2033 (USD Million)
Table 35 Germany cell line development market by source, 2021 – 2033 (USD Million)
Table 36 Germany cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 37 Germany cell line development market by application, 2021 – 2033 (USD Million)
Table 38 France cell line development market by product & services, 2021 – 2033 (USD Million)
Table 39 France cell line development market by source, 2021 – 2033 (USD Million)
Table 40 France cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 41 France cell line development market by application, 2021 – 2033 (USD Million)
Table 42 Italy cell line development market by product & services, 2021 – 2033 (USD Million)
Table 43 Italy cell line development market by source, 2021 – 2033 (USD Million)
Table 44 Italy cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 45 Italy cell line development market by application, 2021 – 2033 (USD Million)
Table 46 Spain cell line development market by product & services, 2021 – 2033 (USD Million)
Table 47 Spain cell line development market by source, 2021 – 2033 (USD Million)
Table 48 Spain cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 49 Spain cell line development market by application, 2021 – 2033 (USD Million)
Table 50 Denmark cell line development market by product & services, 2021 – 2033 (USD Million)
Table 51 Denmark cell line development market by source, 2021 – 2033 (USD Million)
Table 52 Denmark cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 53 Denmark cell line development market by application, 2021 – 2033 (USD Million)
Table 54 Sweden cell line development market by product & services, 2021 – 2033 (USD Million)
Table 55 Sweden cell line development market by source, 2021 – 2033 (USD Million)
Table 56 Sweden cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 57 Sweden cell line development market by application, 2021 – 2033 (USD Million)
Table 58 Norway cell line development market by product & services, 2021 – 2033 (USD Million)
Table 59 Norway cell line development market by source, 2021 – 2033 (USD Million)
Table 60 Norway cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 61 Norway cell line development market by application, 2021 – 2033 (USD Million)
Table 62 Asia Pacific cell line development market by product & services, 2021 – 2033 (USD Million)
Table 63 Asia Pacific cell line development market by source, 2021 – 2033 (USD Million)
Table 64 Asia Pacific cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 65 Asia Pacific cell line development market by application, 2021 – 2033 (USD Million)
Table 66 Asia Pacific cell line development market by country, 2021 – 2033 (USD Million)
Table 67 China cell line development market by product & services, 2021 – 2033 (USD Million)
Table 68 China cell line development market by source, 2021 – 2033 (USD Million)
Table 69 China cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 70 China cell line development market by application, 2021 – 2033 (USD Million)
Table 71 Japan cell line development market by product & services, 2021 – 2033 (USD Million)
Table 72 Japan cell line development market by source, 2021 – 2033 (USD Million)
Table 73 Japan cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 74 Japan cell line development market by application, 2021 – 2033 (USD Million)
Table 75 India cell line development market by product & services, 2021 – 2033 (USD Million)
Table 76 India cell line development market by source, 2021 – 2033 (USD Million)
Table 77 India cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 78 India cell line development market by application, 2021 – 2033 (USD Million)
Table 79 South Korea cell line development market by product & services, 2021 – 2033 (USD Million)
Table 80 South Korea cell line development market by source, 2021 – 2033 (USD Million)
Table 81 South Korea cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 82 South Korea cell line development market by application, 2021 – 2033 (USD Million)
Table 83 Australia cell line development market by product & services, 2021 – 2033 (USD Million)
Table 84 Australia cell line development market by source, 2021 – 2033 (USD Million)
Table 85 Australia cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 86 Australia cell line development market by application, 2021 – 2033 (USD Million)
Table 87 Thailand cell line development market by product & services, 2021 – 2033 (USD Million)
Table 88 Thailand cell line development market by source, 2021 – 2033 (USD Million)
Table 89 Thailand cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 90 Thailand cell line development market by application, 2021 – 2033 (USD Million)
Table 91 Latin America cell line development market by product & services, 2021 – 2033 (USD Million)
Table 92 Latin America cell line development market by source, 2021 – 2033 (USD Million)
Table 93 Latin America cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 94 Latin America cell line development market by application, 2021 – 2033 (USD Million)
Table 95 Latin America cell line development market by country, 2021 – 2033 (USD Million)
Table 96 Brazil cell line development market by product & services, 2021 – 2033 (USD Million)
Table 97 Brazil cell line development market by source, 2021 – 2033 (USD Million)
Table 98 Brazil cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 99 Brazil cell line development market by application, 2021 – 2033 (USD Million)
Table 100 Argentina cell line development market by product & services, 2021 – 2033 (USD Million)
Table 101 Argentina cell line development market by source, 2021 – 2033 (USD Million)
Table 102 Argentina cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 103 Argentina cell line development market by application, 2021 – 2033 (USD Million)
Table 104 Middle East & Africa cell line development market by product & services, 2021 – 2033 (USD Million)
Table 105 Middle East & Africa cell line development market by source, 2021 – 2033 (USD Million)
Table 106 Middle East & Africa cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 107 Middle East & Africa cell line development market by application, 2021 – 2033 (USD Million)
Table 108 Middle East & Africa cell line development market by country, 2021 – 2033 (USD Million)
Table 109 South Africa cell line development market by product & services, 2021 – 2033 (USD Million)
Table 110 South Africa cell line development market by source, 2021 – 2033 (USD Million)
Table 111 South Africa cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 112 South Africa cell line development market by application, 2021 – 2033 (USD Million)
Table 113 Saudi Arabia cell line development market by product & services, 2021 – 2033 (USD Million)
Table 114 Saudi Arabia cell line development market by source, 2021 – 2033 (USD Million)
Table 115 Saudi Arabia cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 116 Saudi Arabia cell line development market by application, 2021 – 2033 (USD Million)
Table 117 UAE cell line development market by product & services, 2021 – 2033 (USD Million)
Table 118 UAE cell line development market by source, 2021 – 2033 (USD Million)
Table 119 UAE cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 120 UAE cell line development market by application, 2021 – 2033 (USD Million)
Table 121 Kuwait cell line development market by product & services, 2021 – 2033 (USD Million)
Table 122 Kuwait cell line development market by source, 2021 – 2033 (USD Million)
Table 123 Kuwait cell line development market by type of cell line, 2021 – 2033 (USD Million)
Table 124 Kuwait cell line development market by application, 2021 – 2033 (USD Million)
List of Figures
Fig. 1 Market Others process
Fig. 2 Data triangulation techniques
Fig. 3 Primary Others pattern
Fig. 4 Market Others approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2024 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s analysis
Fig. 14 SWOT analysis
Fig. 15 Global cell line development market: Product & services outlook and key takeaways
Fig. 16 Global cell line development market: Product & services movement analysis
Fig. 17 Global reagents and media market, 2021 – 2033 (USD Million)
Fig. 18 Global equipment market, 2021 – 2033 (USD Million)
Fig. 19 Global automated systems market, 2021 – 2033 (USD Million)
Fig. 20 Global centrifuges market, 2021 – 2033 (USD Million)
Fig. 21 Global bioreactors market, 2021 – 2033 (USD Million)
Fig. 22 Global storage equipment market, 2021 – 2033 (USD Million)
Fig. 23 Global others market, 2021 – 2033 (USD Million)
Fig. 24 Global accessories and consumables market, 2021 – 2033 (USD Million)
Fig. 25 Global cell line development market: Source outlook and key takeaways
Fig. 26 Global cell line development market: Source movement analysis
Fig. 27 Global mammalian cell line market, 2021 – 2033 (USD Million)
Fig. 28 Global non-mammalian cell line market, 2021 – 2033 (USD Million)
Fig. 29 Global insects market, 2021 – 2033 (USD Million)
Fig. 30 Global amphibians market, 2021 – 2033 (USD Million)
Fig. 31 Global cell line development market: Type of cell line outlook and key takeaways
Fig. 32 Global cell line development market: Type of cell line movement analysis
Fig. 33 Global recombinant cell lines market, 2021 – 2033 (USD Million)
Fig. 34 Global hybridomas market, 2021 – 2033 (USD Million)
Fig. 35 Global continuous cell lines market, 2021 – 2033 (USD Million)
Fig. 36 Global primary cell lines market, 2021 – 2033 (USD Million)
Fig. 37 Global cell line development market: Application outlook and key takeaways
Fig. 38 Global cell line development market: Application movement analysis
Fig. 39 Global bioproduction market, 2021 – 2033 (USD Million)
Fig. 40 Global drug discovery market, 2021 – 2033 (USD Million)
Fig. 41 Global toxicity testing market, 2021 – 2033 (USD Million)
Fig. 42 Global tissue engineering market, 2021 – 2033 (USD Million)
Fig. 43 Global others market, 2021 – 2033 (USD Million)
Fig. 44 Global cell line development market: Regional outlook and key takeaways
Fig. 45 North America cell line development market, 2021 – 2033 (USD Million)
Fig. 46 U.S. key country dynamics
Fig. 47 U.S. cell line development market, 2021 – 2033 (USD Million)
Fig. 48 Canada key country dynamics
Fig. 49 Canada cell line development market, 2021 – 2033 (USD Million)
Fig. 50 Mexico key country dynamics
Fig. 51 Mexico cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 52 Europe cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 53 Germany key country dynamics
Fig. 54 Germany cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 55 France key country dynamics
Fig. 56 France cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 57 UK key country dynamics
Fig. 58 UK cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 59 Italy key country dynamics
Fig. 60 Italy cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 61 Spain key country dynamics
Fig. 62 Spain cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 63 Denmark key country dynamics
Fig. 64 Denmark cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 65 Sweden key country dynamics
Fig. 66 Sweden cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 67 Norway key country dynamics
Fig. 68 Norway cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 69 Asia-Pacific cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 70 China key country dynamics
Fig. 71 China cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 72 India key country dynamics
Fig. 73 India cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 74 South Korea key country dynamics
Fig. 75 South Korea cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 76 Japan key country dynamics
Fig. 77 Japan cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 78 Australia key country dynamics
Fig. 79 Australia cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 80 Thailand key country dynamics
Fig. 81 Thailand cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 82 Latin America cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 83 Brazil key country dynamics
Fig. 84 Brazil cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 85 Argentina key country dynamics
Fig. 86 Argentina cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 87 MEA cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 88 South Africa key country dynamics
Fig. 89 South Africa cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 90 Saudi Arabia key country dynamics
Fig. 91 Saudi Arabia cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 92 UAE key country dynamics
Fig. 93 UAE cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 94 Kuwait key country dynamics
Fig. 95 Kuwait cell line development market estimates and forecast, 2021 – 2033 (USD Million)
Fig. 96 Market participant categorization
Fig. 97 Strategy framework
Grand View Researchについて
Grand View Research(グランドビューリサーチ) はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ 1
| シングルユーザ | チーム | エンタープライズ |
| USD 2,950 | USD 3,950 | USD 5,950 |
ライセンスタイプ 2
| シングルユーザ | チーム | エンタープライズ |
| USD 3,950 | USD 4,950 | USD 6,950 |
ライセンスタイプ 3
| シングルユーザ | チーム | エンタープライズ |
| USD 4,950 | USD 5,950 | USD 7,950 |
ライセンスタイプ 4
| シングルユーザ | チーム | エンタープライズ |
| USD 5,950 | USD 6,950 | USD 8,950 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス(インディビジュアルライセンス)
- 1名のみレポートファイル(印刷不可)をご利用いただけます。
- チームライセンス
- 同一企業(関連会社除く)内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
- コーポレートライセンス
- 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
- 「関連会社」の範囲についてはお気軽にお問い合わせください。
- シングルユーザライセンス(インディビジュアルライセンス)
- 納品形態
- オンラインダウンロード
- 納期
- ご注文後1~7営業日 ※レポートにより異なります。
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
最新出版レポート